Caricamento...

Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells

OBJECTIVE: Trastuzumab has been used for the treatment of HER2-positive breast cancer (BC). However, a subset of BC patients exhibited resistance to trastuzumab therapy. Thus, clarifying the molecular mechanism of trastuzumab treatment will be beneficial to improve the treatment of HER2-positive BC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ichikawa, Takehiro, Sato, Fumiaki, Terasawa, Kazuya, Tsuchiya, Soken, Toi, Masakazu, Tsujimoto, Gozoh, Shimizu, Kazuharu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2012
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3288043/
https://ncbi.nlm.nih.gov/pubmed/22384020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0031422
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !